MEDICOX Co., Ltd. (KOSDAQ:054180)

MEDICOX Statistics

Total Valuation

MEDICOX has a market cap or net worth of KRW 12.68 billion. The enterprise value is 20.33 billion.

Market Cap	12.68B
Enterprise Value	20.33B

Important Dates

The last earnings date was Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

MEDICOX has 5.52 million shares outstanding. The number of shares has increased by 57.27% in one year.

Current Share Class	5.52M
Shares Outstanding	5.52M
Shares Change (YoY)	+57.27%
Shares Change (QoQ)	+11.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.42
PB Ratio	0.24
P/TBV Ratio	0.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.15
EV / Sales	0.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.76

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.26.

Current Ratio	0.63
Quick Ratio	0.39
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-2.57
Interest Coverage	-4.11

Financial Efficiency

Return on equity (ROE) is -33.11% and return on invested capital (ROIC) is -7.64%.

Return on Equity (ROE)	-33.11%
Return on Assets (ROA)	-6.67%
Return on Invested Capital (ROIC)	-7.64%
Return on Capital Employed (ROCE)	-14.77%
Revenue Per Employee	488.30M
Profits Per Employee	-285.05M
Employee Count	62
Asset Turnover	0.38
Inventory Turnover	18.93

Taxes

Income Tax	-72.46M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.91% in the last 52 weeks. The beta is -0.35, so MEDICOX's price volatility has been lower than the market average.

Beta (5Y)	-0.35
52-Week Price Change	-75.91%
50-Day Moving Average	2,911.20
200-Day Moving Average	4,459.80
Relative Strength Index (RSI)	41.36
Average Volume (20 Days)	865,845

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MEDICOX had revenue of KRW 30.27 billion and -17.67 billion in losses. Loss per share was -3,859.50.

Revenue	30.27B
Gross Profit	2.33B
Operating Income	-8.61B
Pretax Income	-17.75B
Net Income	-17.67B
EBITDA	-6.58B
EBIT	-8.61B
Loss Per Share	-3,859.50

Balance Sheet

The company has 5.15 billion in cash and 13.86 billion in debt, giving a net cash position of -8.72 billion or -1,577.67 per share.

Cash & Cash Equivalents	5.15B
Total Debt	13.86B
Net Cash	-8.72B
Net Cash Per Share	-1,577.67
Equity (Book Value)	52.31B
Book Value Per Share	9,468.27
Working Capital	-7.05B

Cash Flow

In the last 12 months, operating cash flow was -4.67 billion and capital expenditures -732.34 million, giving a free cash flow of -5.40 billion.

Operating Cash Flow	-4.67B
Capital Expenditures	-732.34M
Free Cash Flow	-5.40B
FCF Per Share	-977.15

Margins

Gross margin is 7.70%, with operating and profit margins of -28.43% and -58.38%.

Gross Margin	7.70%
Operating Margin	-28.43%
Pretax Margin	-58.62%
Profit Margin	-58.38%
EBITDA Margin	-21.73%
EBIT Margin	-28.43%
FCF Margin	n/a

Dividends & Yields

MEDICOX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.27%
Shareholder Yield	n/a
Earnings Yield	-139.39%
FCF Yield	-42.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 16, 2022. It was a forward split with a ratio of 2.

Last Split Date	Nov 16, 2022
Split Type	Forward
Split Ratio	2

Scores

MEDICOX has an Altman Z-Score of -1.39 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.39
Piotroski F-Score	3